Cargando…

The Effect of Thermal-Treating on Drug Release from Sustained Release Alginate-Eudragit RS Matrices

Purpose: The main objective of the present study was to develop the colonic delivery system for 5-aminosalicylic acid (5-ASA) as an anti-inflammatory drug. Methods: Matrix pellets containing various proportions of alginate, calcium and Eudragit(®) RS were prepared by extrusion-spheronization techniq...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaffash, Ehsan, Abbaspour, Mohammadreza, Afrasiabi Garekani, Hadi, Jahanian, Zohreh, Saremnejad, Farinaz, Akhgari, Abbas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tabriz University of Medical Sciences 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046385/ https://www.ncbi.nlm.nih.gov/pubmed/33880354 http://dx.doi.org/10.34172/apb.2021.027

Ejemplares similares

The effect of pectin on swelling and permeability characteristics of free films containing Eudragit RL and/or RS as a coating formulation aimed for colonic drug delivery
por: Akhgari, A., et al.
Publicado: (2010)

Combination of Pectin and Eudargit RS and Eudragit RL in the Matrix of Pellets Prepared by Extrusion-Spheronization for Possible Colonic Delivery of 5-Amino Salicylic Acid
por: Akhgari, Abbas, et al.
Publicado: (2013)

Evaluation of ethylcellulose and its pseudolatex (Surelease) in preparation of matrix pellets of theophylline using extrusion-spheronization
por: Garekani, Hadi Afrasiabi, et al.
Publicado: (2017)

Production of Ibuprofen Pellets Containing High Amount of Rate Retarding Eudragit RL Using PEG400 and Investigation of Their Physicomechanical Properties
por: Sadeghi, Fatemeh, et al.
Publicado: (2011)

Synthesis of a novel PEGylated colon-specific azo-based 4- aminosalicylic acid prodrug
por: Sadeghi, Fatemeh, et al.
Publicado: (2020)

Preparation and Characterization of a Novel Multiparticulate Dosage Form Carrying Budesonide-Loaded Chitosan Nanoparticles to Enhance the Efficiency of Pellets in the Colon
por: Soltani, Fatemeh, et al.
Publicado: (2022)

Disulfide Bridged Nanoparticles of Thiolated Sodium Alginate and Eudragit RS100 for Oral Delivery of Paclitaxel: In Vitro and In Vivo Evaluation
por: Khalid, Hafiz Muhammad Bilal, et al.
Publicado: (2023)

Eudragit(®) Microparticles for the Release of Budesonide: A Comparative Study
por: Cortesi, Rita, et al.
Publicado: (2012)

Structural Characterization of Calcium Alginate Matrices by Means of Mechanical and Release Tests
por: Grassi, Mario, et al.
Publicado: (2009)

Nanoformulated Eudragit lopinavir and preliminary release of its loaded suppositories
por: Katata-Seru, Lebogang, et al.
Publicado: (2020)

Effect of Eudragit S100 nanoparticles and alginate chitosan encapsulation on the viability of Lactobacillus acidophilus and Lactobacillus rhamnosus
por: Ansari, Fereshteh, et al.
Publicado: (2017)

In Vitro Evaluation of Eudragit Matrices for Oral Delivery of BCG Vaccine to Animals
por: Saleem, Imran, et al.
Publicado: (2019)

Preparation and Evaluation of Mixture of Eudragit and Ethylcellulose Microparticles Loaded with Ranolazine for Controlled Release
por: Gowda, DV, et al.
Publicado: (2011)

The Effect of Molecular Properties on Active Ingredient Release from Electrospun Eudragit Fibers
por: Burgess, Kieran, et al.
Publicado: (2018)

Statistical Optimization of Oral Vancomycin-Eudragit RS Nanoparticles Using Response Surface Methodology
por: Delf Loveymi, Badir, et al.
Publicado: (2012)

Effect of permeation enhancers on in vitro release and transdermal delivery of lamotrigine from Eudragit(®)RS100 polymer matrix-type drug in adhesive patches
por: Jafri, Ifrah, et al.
Publicado: (2019)

Formulation and in vitro Evaluation of Alfuzosin Extended Release Tablets Using Directly Compressible Eudragit
por: Roni, M. A., et al.
Publicado: (2009)

Development of Lyophilised Eudragit(®) Retard Nanoparticles for the Sustained Release of Clozapine via Intranasal Administration
por: Lombardo, Rosamaria, et al.
Publicado: (2023)

Development and Characterization of Eudragit-RL-100-Based Aceclofenac Sustained-Release Matrix Pellets Prepared via Extrusion/Spheronization
por: Ibrahim, Mohamed Abbas, et al.
Publicado: (2021)

Comparison of physicomechanical properties of films prepared from organic solutions and aqueous dispersion of Eudragit RL
por: Sadeghi, F., et al.
Publicado: (2011)

Physicochemical and pharmacological evaluation of carvedilol-eudragit(®) RS100 electrosprayed nanostructures
por: Selselehjonban, Sevil, et al.
Publicado: (2019)

Preparation of stable enteric folic acid-loaded microfiber using the electrospinning method
por: Akhgari, Abbas, et al.
Publicado: (2022)

In vitro-in vivo evaluation of xanthan gum and eudragit inter polyelectrolyte complex based sustained release tablets
por: Deb, Tamal Krishna, et al.
Publicado: (2015)

Development and Characterization of Eudragit(®)-Based Electrospun Nanofibrous Mats and Their Formulation into Nanofiber Tablets for the Modified Release of Furosemide
por: Vlachou, Marilena, et al.
Publicado: (2019)

Preparation, Optimization and in vitro Evaluation of Glipizide Nanoparticles Integrated with Eudragit RS-100
por: Saharan, P., et al.
Publicado: (2019)

Formulation, characterization and evaluation of the effect of polymer concentration on the release behavior of insulin-loaded Eudragit(®)-entrapped mucoadhesive microspheres
por: Kenechukwu, Franklin C., et al.
Publicado: (2016)

Preparation and characterization of celecoxib solid dispersions; comparison of poloxamer-188 and PVP-K30 as carriers
por: Homayouni, Alireza, et al.
Publicado: (2014)

Improvement of Physico-mechanical Properties of Partially Amorphous Acetaminophen Developed from Hydroalcoholic Solution Using Spray Drying Technique
por: Sadeghi, Fatemeh, et al.
Publicado: (2013)

Preparation and Characterization of Celecoxib Dispersions in Soluplus(®): Comparison of Spray Drying and Conventional Methods
por: Homayouni, Alireza, et al.
Publicado: (2015)

Equilibrium and Release Properties of Aqueous Dispersions of Non-Steroidal Anti-Inflammatory Drugs Complexed with Polyelectrolyte Eudragit E 100
por: Quinteros, Daniela Alejandra, et al.
Publicado: (2012)

Preparation, Evaluation and Bioavailability Studies of Eudragit Coated PLGA Nanoparticles for Sustained Release of Eluxadoline for the Treatment of Irritable Bowel Syndrome
por: Anwer, Md. K., et al.
Publicado: (2017)

Vaginal Polyelectrolyte Layer-by-Layer Films Based on Chitosan Derivatives and Eudragit(®) S100 for pH Responsive Release of Tenofovir
por: Cazorla-Luna, Raúl, et al.
Publicado: (2020)

Sustained Release of Risedronate from PLGA Microparticles Embedded in Alginate Hydrogel for Treatment of Bony Lesions
por: Azari, Ghazaleh, et al.
Publicado: (2022)

Nanostructured lipid carrier surface modified with Eudragit RS 100 and its potential ophthalmic functions
por: Zhang, Wenji, et al.
Publicado: (2014)

Flavour distribution and release from gelatine-starch matrices
por: Su, Katy, et al.
Publicado: (2021)

Hyaluronan–cisplatin conjugate nanoparticles embedded in Eudragit S100-coated pectin/alginate microbeads for colon drug delivery
por: Tsai, Shiao-Wen, et al.
Publicado: (2013)

New Alginate/PNIPAAm Matrices for Drug Delivery
por: Cheaburu-Yilmaz, Catalina N., et al.
Publicado: (2019)

Core–Shell Eudragit S100 Nanofibers Prepared via Triaxial Electrospinning to Provide a Colon-Targeted Extended Drug Release
por: Ding, Yanfei, et al.
Publicado: (2020)

Electrophoretically Deposited Chitosan/Eudragit E 100/AgNPs Composite Coatings on Titanium Substrate as a Silver Release System
por: Pawłowski, Łukasz, et al.
Publicado: (2021)

Dual-Responsive Alginate Hydrogels for Controlled Release of Therapeutics
por: Lin, Xuexia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ev46umkjjr3b1cbggplv4hf2gd